IQVIA and Veeva extend their partnership, expanding sponsor access to Veeva's clinical trial and data management technology.

In recent years, automation and artificial intelligence (AI) have been huge trends within the clinical trials landscape, as companies look to incorporate such technologies to optimise their ...

An analysis of 254 registered clinical trials shows digital therapeutics are dominated by mobile apps targeting psychiatric ...

The clinical trial landscape in 2025 was characterised by technological advancements, regulatory innovations, and a focus on diversity and patient engagement, alongside challenges such as declining ...

Clinical trials are crucial for evidence generation on medicines. As of June, 2025, the European Union’s (EU) clinical trial ...

Multi-trial agreement establishes a standardized digital foundation to support consistent, scalable execution across global studies NEW YORK, Feb. 24, 2026 /PRNewswire/ -- ObvioHealth, a global leader ...

Digit health technologies (DHT) are a key aspect of U.S. Health & Human Services (HHS) Secretary Robert F. Kennedy Jr.’s Make America Healthy Again (MAHA) agenda. DHTs are health care focused ...

Drug development is an inherently risky endeavour, with the average probability of approval for a drug entering Phase I studies now sitting at just 6.7%. While much of this can be attributed to lack ...

Decentralized Clinical Trials Market was valued at USD 8.70 billion in 2025 and is expected to reach USD 32.50 billion by 2035, growing at a CAGR of 14.12% from 2026-2035.